GenScript Biotech and the Diagnostics Development Hub (DxD) at Singapore’s Agency for Science, Technology and Research (A*STAR) alongside Singapore’s Duke-NUS Medical School have entered into an exclusive deal whereby they will both co-develop and manufacture the serological COVID-19 detection system, otherwise known as the cPass or surrogate virus neutralization tests (sVNT). The first of its […]
Subscribe to our latest newsletter and never miss the latest news!
Our newsletter is sent once a week, every Wednesday.